Xofigo 1100 kBq/mL (30 microcurie/mL) with a total radioactivity of 6,600 kBq/vial (178 microcurie/vial) Images

Generic Name: radium 223 dichloride

This medication has been identified as Xofigo 1100 kBq/mL (30 microcurie/mL) with a total radioactivity of 6,600 kBq/vial (178 microcurie/vial). It is supplied by Bayer HealthCare Pharmaceuticals Inc.

Xofigo is used in the treatment of Prostate Cancer and belongs to the drug class therapeutic radiopharmaceuticals. Not for use in pregnancy. Xofigo 1100 kBq/mL (30 microcurie/mL) with a total radioactivity of 6,600 kBq/vial (178 microcurie/vial) is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Xofigo

Generic Name

radium 223 dichloride

Strength

1100 kBq/mL (30 microcurie/mL) with a total radioactivity of 6,600 kBq/vial (178 microcurie/vial)

Availability

Prescription only

Drug Class

Therapeutic radiopharmaceuticals

Pregnancy Category

X - Not for use in pregnancy

CSA Schedule

Not a controlled drug

Labeler / Supplier

Bayer HealthCare Pharmaceuticals Inc.

National Drug Code (NDC)

50419-0208

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer